OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
Lisha Cai, Xiaoling Xu, Wei Chen
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1647-1647
Open Access | Times Cited: 9
Lisha Cai, Xiaoling Xu, Wei Chen
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1647-1647
Open Access | Times Cited: 9
Showing 9 citing articles:
Evaluation of Different Commercial Sealing Hemostatic Patches for Their Selection as Reservoirs for Localized Intraperitoneal Chemotherapy
M. Teresa Perelló-Trias, Ana Rodríguez-Fernández, Antonio Jose Serrano-Muñoz, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 499-509
Open Access
M. Teresa Perelló-Trias, Ana Rodríguez-Fernández, Antonio Jose Serrano-Muñoz, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 499-509
Open Access
PARP1: A comprehensive review of its mechanisms, therapeutic implications and emerging cancer treatments
Carlota J.F. Conceição, Elin Moe, Paulo A. Ribeiro, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189282-189282
Open Access
Carlota J.F. Conceição, Elin Moe, Paulo A. Ribeiro, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189282-189282
Open Access
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8304-8304
Open Access | Times Cited: 4
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8304-8304
Open Access | Times Cited: 4
Hypoxic regulation of extracellular vesicles: Implications for cancer therapy
Seongkyeong Yoo, Sanga Choi, Iljin Kim, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 201-220
Closed Access | Times Cited: 10
Seongkyeong Yoo, Sanga Choi, Iljin Kim, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 201-220
Closed Access | Times Cited: 10
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
Ornella Franzese, Grazia Graziani
Cancers (2022) Vol. 14, Iss. 22, pp. 5633-5633
Open Access | Times Cited: 15
Ornella Franzese, Grazia Graziani
Cancers (2022) Vol. 14, Iss. 22, pp. 5633-5633
Open Access | Times Cited: 15
Improving the physicochemical and pharmacokinetic properties of olaparib through cocrystallization strategy
Xia-Lin Dai, Bowen Pang, Wenting Lv, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123497-123497
Closed Access | Times Cited: 7
Xia-Lin Dai, Bowen Pang, Wenting Lv, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123497-123497
Closed Access | Times Cited: 7
Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids
Aaron J. Sorrin, Anika Dasgupta, Kathryn A. McNaughton, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Aaron J. Sorrin, Anika Dasgupta, Kathryn A. McNaughton, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation
Flurina Böhi, Michael O. Hottiger
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1617-1617
Open Access | Times Cited: 1
Flurina Böhi, Michael O. Hottiger
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1617-1617
Open Access | Times Cited: 1
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies
Rong Wang, Yunxi Liu, Mingqi Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125028-125028
Closed Access | Times Cited: 1
Rong Wang, Yunxi Liu, Mingqi Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125028-125028
Closed Access | Times Cited: 1
